Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
 
Program Contents
bullet Topic Home
bullet Mycotic Diseases
bullet Current Research
bullet Training / Research
Opportunities
  bullet Reference Services
  bullet Related Links
  bullet What's New
  bullet Goals
  bullet Publications
  bullet Staff
Contact Info

1600 Clifton Road NE, MS-G11
Atlanta, GA 30033
Phone: + 1-800-311-3435

 
Division of Bacterial and Mycotic Diseases, Mycotic Diseases Branch

What's New with our Publications | Staff

 New Publication

2006

  1. Chowdhary A., W. Lee-Yang, B.A. Lasker , M.E. Brandt, D.W. Warnock, and B.A. Arthington-Skaggs. Comparison of multilocus typing (MLST) and Ca3 fingerprinting for molecular subtyping of epidemiologically-related and geographically-distinct clinical isolates of Candida albicans. Med. Mycol. 2006; 44:405-417.
  2. Lasker B.A., G. Butler and T.J. Lott. Molecular genotyping of Candida parapsilosis Group I clinical isolates by analysis of polymorphic microsatellite markers. J.Clin. Microbiol. 2006; 44: 750-759.
  3. Ghannoum, M.A., Arthington-Skaggs, B.A., Brown, S.A., Chaturvedi, V., Espinel-Ingroff, A., Pfaller, M.A., Rennie, R., Rinaldi, M.G. and Walsh, T.J. 2006. An Interlaboratory study of quality control isolates for a broth antifungal susceptibility method for the testing of dermatophytes (modified CLSI M38-A). J. Clin. Microbiol. 2006; 44:4353-4356.
  4. Morgan, J., McCarthy, K.M., Gould, S., Fan, K., Arthington-Skaggs, B., Iqbal, N., Stamey, K., Hajjeh, R.A., Brandt , M.E. for the Gauteng Cryptococcal Surveillance Initiative Group. 2006. Cryptococcus gattii Infection: Characteristics and Epidemiology of Cases Identified in a South African Province with High HIV Seroprevalence, 2002-2004. Clin. Infect. Dis. 2006; 43:1077-1080.
  5. Colombo, A.L., Nucci, M., Park, B.J., Nouer, S.A., Arthington-Skaggs, B., da Matta, D.A., Warnock, D., and Morgan, J. 2006. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol. 44:2816-2823.
  6. Sofair, A.N., Lyon, G.M., Huie-White, S., Reiss, E., Harrison , L.H., Thomson Sanza, L., Arthington-Skaggs, B.A., and Fridkin, S.K. 2006. Epidemiology of community-onset candidemia in Connecticut and Maryland. Clin. Infect. Dis. 43:32-39.
  7. Park, B.J., Arthington-Skaggs, B.A., Hajjeh, R.A., Iqbal, N., Ciblak, M.A., Lee-Yang, W., Hariston, M.D., Phelan, M., Plikaytis, B.D., Sofair, A.N., Harrison, L.H., Fridkin, S.K., and Warnock, D.W. 2006. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Anticrob. Agents Chemother. 50:1287-1292.
  8. McCarthy, K.M., J. Morgan, K.A. Wannemuehler, S.A. Mirza, S.M. Gould, N. Mhlongo, P. Moeng, B.R. Maloba, H.H. Crewe-Brown , M.E. Brandt and R.A. Hajjeh for the Gauteng Cryptococcal Surveillance Initiative Group. Population-based surveillance for cryptococcosis in an antiretroviral naïve South African province with high HIV seroprevalence. AIDS 2006;20: 2199-2206.
  9. CDC (2006) Surveillance for Illness and Injury After Hurricane Katrina - Three Counties , Mississippi , September 5-October 11, 2005 , MMWR 55(9):231-234.
  10. CDC (2006) Health Concerns Associated with Mold in Water-damaged Homes After Hurricanes Katrina and Rita - New Orleans Area, Louisiana, October 2005, MMWR 55(2):41-44.
  11. Park J.H., Cox-Ganser J., Rao C., Kriess, K. Fungal and endotoxin measurements in dust associated with respiratory symptoms in a water-damaged office building. Indoor Air 2006; 6:192-203.
  12. Rodriguez D., Almirante B., Park B.J., Cuenca-Estrella M., Planes A., Sanchez F., Amadeu G., Xercavins M., Fontanals D., Rodriguez-Tudela J., Warnock D., Pahissa A.; Barcelona Candidemia Project Study Group, Candidemia in Neonatal Intensive Care Units - Barcelona, Spain. Pediatr. Infect Dis. J. 2006. 25: 224-229.
  13. Fridkin SK, Kaufman D., Edwards J.R., Shetty S., Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics. 2006;117:1680-7.
  14. Lasker, B.A. Nucleotide sequence-based analysis for determining the molecular epidemiology of Penicillium marneffei. J. Clin. Microbiol. 2006; 44 : 3145-3153.
  15. LeMaile-Williams M., Burwell L.A., Salisbury D., Noble-Wang J., Arduino M., Lott T., Brandt M.E., Iiames S., Srinivasan A., Fridkin S.K. Outbreak of Cutaneous Infections with Rhizopus arrhizus Associated with Karaya Ostomy Bags. Clin. Infect. Dis., 2006; 43: e83-88.
  16. Smith P.B., Morgan J., Benjamin D.K., Fridkin S.K., Sanza L., Harrison L.H., Sofair A.N., Huie-White G., Wilcox S., Benjamin Jr D.K. Excess Costs of Hospital Care Associated with Neonatal Candidemia. Ped. Infect. Dis. J. 2006 in press
  17. CDC (2003) Preliminary Clinical Description of Severe Acute Respiratory Syndrome. MMWR Morb Mortal Wkly Rep 2003. 52(12);255-256
  18. CDC (2003) Increase in Coccidioidomycosis --- Arizona, 1998-2001. MMWR Morb Mortal Wkly Rep.2003. 52(06);109-112
  19. CDC (2006) Update: Fusarium keratitis-United States, 2005-2006. MMWR Morb Mortal Wkly Rept 2006. 55(20);563-564.
  20. CDC (2006) Fusarium keratitis-multiple states, 2006. MMWR Morb Mortal Wkly Rept 2006. 55(14);400-401.
  21. D.C. Chang, G.B. Grant, K.O'Donnell, K. Wannemuehler, J. Noble-Wang, C.Y. Rao , L. Jacobson, C. Crowell, R. Sneed, F.M.T. Lewis, M.Kainer, C. Genese, E.C. Alfonso, D.B. Jones, A. Srinivasan, S.K. Fridkin, and B.J. Park for the Fusarium Keratitis Investigation Team. An outbreak of Fusarium keratitis associated with use of a new contact lens solution. JAMA 2006. 296 (8): 953-63.
  22. L.A. Burwell, D. Kaufman, J. Blakely, B.J. Stoll, and S.K. Fridkin. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics 2006. 118 (4); e1019-1024.
  23. Clark, T, G.D. Huhn, C. Conover, S. Cali, M.J. Arduino, R. Hajjeh, M.E. Brandt, and S. K. Fridkin. Outbreak of bloodstream infection with the mold Phialemonium among patients receiving dialysis at a hemodialysis unit. Infect. Control Hosp. Epidemiol. 2006. 27;1164-1170.

 New Staff

Arunmozhi Balajee, Ph.D joined the staff in 2006 from the Fred Hutchison Cancer Center in Seattle. Dr. Balajee has an accomplished publication record in the field of molecular identification and subtyping, particularly with the genus Aspergillus. She identified the new species Aspergillus lentulus in immunocompromised patients. Dr. Balajee will be the Chief of the Molecular Subtyping Unit in the Branch.

Debra Wagner joined the staff of the epidemiology unit in 2006 as an ORISE Fellow. Ms. Wagner recently completed her MPH at Emory University. In her new position of Surveillance Coordinator, she will be coordinating the aspects of the OTIP Study for fungal infections in transplant patients. She will be accessing and reviewing data received from the six cooperating sites of this study.

Thomas Chiller, MD joined the staff in Jan 2007 as the Chief of the Epidemiology Unit. Prior to his appointment, he was the head of the NARMS (National Antimicrobial Resistance Monitoring System for Enteric Bacteria) Program in the Enteric Diseases Epidemiology Branch, DFBMD. A physician board-certified in internal medicine and infectious diseases, Dr. Chiller also completed a postdoctoral fellowship in the laboratory of David Stevens at Stanford University, where he developed his interest in fungal infections. Dr. Chiller brings his extensive national and international experience in surveillance and control of infectious diseases to the mycotic diseases arena.

 
 
Date: January 3, 2007
Content source: Coordinating Center for Infectious Diseases / Division of Bacterial and Mycotic Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435